Emerald Health Bioceuticals Inc. — Form D
Emerald Health Bioceuticals Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-03-19. The offering totals $5.0M, of which $52K was reported sold. Industry: Retailing.
Offering
- Filed: 2020-03-19
- Form: D
- Accession: 0001567619-20-006776
- Industry: Retailing
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $52K
- Remaining: $4.9M
- Investors: 5
- Date of first sale: 2020-03-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-363301
Issuer
- Name: Emerald Health Bioceuticals Inc.
- CIK: 0001713164
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 5910 PACIFIC CENTER BLVD, SUITE 300, SAN DIEGO, CA, 92121
- Phone: 1-858-947-8269
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Margaret Dalesamdro | Director | San Diego, CA |
| Punit Dhillon | Director | San Diego, CA |
| Jim Heppell | Director | Vancouver, A1 |
| Gaetano Morello | Director | Vancouver, A1 |
| Tu Diep | Executive Officer | San Diego, CA |
| Gaetano Morello | Executive Officer | Vancouver, A1 |
| Elena Traistaru | Executive Officer | San Diego, CA |
| Jill Broadfoot | Executive Officer | Hayward, CA |
| Dr. Avtar Dhillon | Director | San Diego, CA |
| Dr. Avtar Dhillon | Executive Officer | San Diego, CA |
| Jade Beutler | Executive Officer | San Diego, CA |
| Dr. Gaetano Morello | Director | San Diego, CA |
Other filings by this issuer (2)
More